864773-64-8

Basic information

• Product Name: 1-(5-Bromo-2,4-difluoro-phenyl)-ethanone
• Synonyms: 1-(5-Bromo-2,4-difluoro-phenyl)-ethanone;5'-Bromo-2',4'-difluoroacetophenone;5'-Bromo-2',4'-difluoroacetophenone 98%;1-(5-Bromo-2,4-difluorophenyl)ethan-1-one;5-broMo-2,4-difluoroacetophenobe;Ethanone, 1-(5-bromo-2,4-difluorophenyl)-;1-(5-Bromo-2,4-difluorophenyl)
• CAS NO: 864773-64-8
• Molecular Formula: C₈H₅BrF₂O
• Molecular Weight: 235.027
• Mol File: 864773-64-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 254.0±40.0 °C(Predicted)
• Appearance: /
• Density: 1.614±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(5-Bromo-2,4-difluoro-phenyl)-ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-Bromo-2,4-difluoro-phenyl)-ethanone(864773-64-8)
• EPA Substance Registry System: 1-(5-Bromo-2,4-difluoro-phenyl)-ethanone(864773-64-8)

Safety Data

• Hazardous Substances Data: 864773-64-8(Hazardous Substances Data)

Usage

General Description

1-(5-Bromo-2,4-difluoro-phenyl)-ethanone is a chemical compound with the molecular formula C8H6BrF2O. It is a yellow to brown crystalline solid with a molecular weight of 229.04 g/mol. 1-(5-Bromo-2,4-difluoro-phenyl)-ethanone is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has a wide range of applications in the pharmaceutical industry, such as in the production of anti-inflammatory and analgesic drugs. Additionally, it is also used as a building block in the synthesis of various organic compounds, making it a valuable and versatile chemical in the field of organic chemistry.

Upstream product

• 28342-75-8 1,5-dibromo-2,4-difluorobenzene 
• 78191-00-1 N-Methoxy-N-methylacetamide 
• 348-57-2 2,4-difluorobromobenzene 
• 75-36-5 acetyl chloride 

Downstream Products

• 1616100-66-3 tert-butyl ((4S,6S)-4-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-6-(3,5-dimethylisoxazol-4-yl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-yl)carbamate 
• 1616100-65-2 tert-butyl (4S,6S)-4-(5-bromo-2,4-difluorophenyl)-6-(3,5-dimethylisoxazol-4-yl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-ylcarbamate 
• 1616100-64-1 (4S,6S)-4-(5-bromo-2,4-difluorophenyl)-6-(3,5-dimethylisoxazol-4-yl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine 
• 1346145-52-5 (R,E)-N-(1-(5-bromo-2,4-difluorophenyl)ethylidene)-2-methylpropane-2-sulfinamide 
• 1585971-26-1 (R)-N-((S)-2-(5-bromo-2,4-difluorophenyl)-4-(3,5-dimethylisoxazol-4-yl)-4-oxobutan-2-yl)-2-methylpropane-2-sulfinamide 
• 1585971-25-0 (R)-N-((2S,4R)-2-(5-bromo-2,4-difluorophenyl)-4-(3,5-dimethylisoxazol-4-yl)-4-hydroxybutan-2-yl)-2-methylpropane-2-sulfinamide 
• 1585971-22-7 (1R,3S)-3-amino-3-(5-bromo-2,4-difluorophenyl)-1-(3,5-dimethylisoxazol-4-yl)butan-1-ol 
• 1616100-60-7 tert-butyl ((2S,4R)-2-(5-bromo-2,4-difluorophenyl)-4-(3,5-dimethylisoxazol-4-yl)-4-hydroxybutan-2-yl)carbamate 
• 1616100-59-4 (S)-tert-butyl (2-(5-bromo-2,4-difluorophenyl)-4-oxobutan-2-yl)carbamate 
• 1616100-58-3 (S)-tert-butyl (2-(5-bromo-2,4-difluorophenyl)-4-hydroxybutan-2-yl)carbamate 
• 1194044-43-3 (S)-3-amino-3-(5-bromo-2,4-difluorophenyl)butan-1-ol 
• 1585971-23-8 (R)-N-((S)-2-(5-bromo-2,4-difluorophenyl)-4-hydroxybutan-2-yl)-2-methylpropane-2-sulfinamide 
• 1194044-31-9 (S)-methyl 3-(5-bromo-2,4-difluorophenyl)-3-((R)-1,1-dimethylethylsulfinamido)butanoate 

Relevant articles and documents

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

The present invention relates to novel triazolo[4,3-a]pyridine derivatives of Formula (I) wherein all radicals are as defined in the claims. The compounds according to the invention are positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (“mGluR2”), which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds for the prevention or treatment of neurological and psychiatric disorders and diseases in which mGluR2 is involved.

5-AMINO-3,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

The present invention relates to novel 5-amino-3,6-dihydro-1H-pyrazin-2-one derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical com

INHIBITORS OF AKT ACTIVITY

Invented are novel pyridine compounds, the use of such compounds as inhibitors of PKB/AKT kinase activity and in the treatment of cancer and arthritis.